High Performance Oxytetracycline Use - dexamethasone sodium phosphate injection – Xinanran
High Performance Oxytetracycline Use - dexamethasone sodium phosphate injection – Xinanran Detail:
[ Adverse reaction ] (1) There were strong water and sodium retention and potassium excretion.
(2) Has strong immunosuppressive effect.
(3) High dose use in late pregnancy might cause abortion.
[ Notice ] (1) It is contra-indicated in pregnant animals at earlier or late stages.
(2) In case of bacterial infections it should be combined with antimicrobial agents.
(3) Long-term medication should not be discontinued suddenly, the dosage gradually reduced until discontinuation.
[Withdrawal period] Cattle, sheep and pigs 21 days; The milk abandonment period is 72 hours.
[ Specification ] (1) 1ml:1mg (2) 5ml:5mg
[Storage] Shading the light and keeping it in a closed manner.
[Period of validity] Two years
[Manufacturing enterprise ] Hebei XinAnRan Biotechnology Co., Ltd
[Factory address] No. 6 First Row East, Konggang Street Economic Development Zone, Xinle City, Hebei Province.
Product detail pictures:
Related Product Guide:
Persisting in "High quality, Prompt Delivery, Aggressive Price", now we have established long-term cooperation with consumers from equally overseas and domestically and get new and old clients' large comments for High Performance Oxytetracycline Use - dexamethasone sodium phosphate injection – Xinanran , The product will supply to all over the world, such as: Milan, Karachi, Bahamas, We have advanced production technology, and pursuit innovative in goods. At the same time, the good service has enhanced the good reputation. We believe that as long as you understand our product, you need to be willing to become partners with us. Looking forward to your inquiry.
By Penelope from Croatia - 2018.10.31 10:02
The company keeps to the operation concept "scientific management, high quality and efficiency primacy, customer supreme", we have always maintained business cooperation. Work with you,we feel easy!
By Jo from Karachi - 2018.12.25 12:43
